
Home » Biosensors Obtains CE Mark for Drug-Coated Coronary Stent
Biosensors Obtains CE Mark for Drug-Coated Coronary Stent
Biosensors has earned a CE mark certification for its BioFreedom Ultra drug-coated coronary stent system.
The new, thin-strut stent is designed to optimize coronary procedures for patients at high risk of bleeding. The 84-micrometer device delivers the company’s proprietary drug, Biolimus A9, that promotes rapid growth of vascular tissue for one month.
Biosensors said it also is developing a Biolimus A9-eluting device for the treatment of patients with coronary artery disease.
Upcoming Events
-
08Feb
-
09Feb
-
15Feb
-
16Feb
-
22Feb
-
07Mar